Your browser doesn't support javascript.
loading
NCCN Guidelines® Insights: Breast Cancer, Version 4.2021.
Gradishar, William J; Moran, Meena S; Abraham, Jame; Aft, Rebecca; Agnese, Doreen; Allison, Kimberly H; Blair, Sarah L; Burstein, Harold J; Dang, Chau; Elias, Anthony D; Giordano, Sharon H; Goetz, Matthew P; Goldstein, Lori J; Hurvitz, Sara A; Isakoff, Steven J; Jankowitz, Rachel C; Javid, Sara H; Krishnamurthy, Jairam; Leitch, Marilyn; Lyons, Janice; Matro, Jennifer; Mayer, Ingrid A; Mortimer, Joanne; O'Regan, Ruth M; Patel, Sameer A; Pierce, Lori J; Rugo, Hope S; Sitapati, Amy; Smith, Karen Lisa; Smith, Mary Lou; Soliman, Hatem; Stringer-Reasor, Erica M; Telli, Melinda L; Ward, John H; Wisinski, Kari B; Young, Jessica S; Burns, Jennifer L; Kumar, Rashmi.
Afiliación
  • Gradishar WJ; 1Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
  • Moran MS; 2Yale Cancer Center/Smilow Cancer Hospital.
  • Abraham J; 3Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.
  • Aft R; 4Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.
  • Agnese D; 5The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.
  • Allison KH; 6Stanford Cancer Institute.
  • Blair SL; 7UC San Diego Moores Cancer Center.
  • Burstein HJ; 8Dana-Farber/Brigham and Women's Cancer Center.
  • Dang C; 9Memorial Sloan Kettering Cancer Center.
  • Elias AD; 10University of Colorado Cancer Center.
  • Giordano SH; 11The University of Texas MD Anderson Cancer Center.
  • Goetz MP; 12Mayo Clinic Cancer Center.
  • Goldstein LJ; 13Fox Chase Cancer Center.
  • Hurvitz SA; 14UCLA Jonsson Comprehensive Cancer Center.
  • Isakoff SJ; 15Massachusetts General Hospital Cancer Center.
  • Jankowitz RC; 16Abramson Cancer Center at the University of Pennsylvania.
  • Javid SH; 17Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance.
  • Krishnamurthy J; 18Fred & Pamela Buffet Cancer Center.
  • Leitch M; 19UT Southwestern Simmons Comprehensive Cancer Center.
  • Lyons J; 3Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.
  • Matro J; 16Abramson Cancer Center at the University of Pennsylvania.
  • Mayer IA; 20Vanderbilt-Ingram Cancer Center.
  • Mortimer J; 21City of Hope National Medical Center.
  • O'Regan RM; 22University of Wisconsin Carbone Cancer Center.
  • Patel SA; 13Fox Chase Cancer Center.
  • Pierce LJ; 23University of Michigan Rogel Cancer Center.
  • Rugo HS; 24UCSF Helen Diller Family Comprehensive Cancer Center.
  • Sitapati A; 7UC San Diego Moores Cancer Center.
  • Smith KL; 25The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
  • Smith ML; 26Research Advocacy Network.
  • Soliman H; 27Moffitt Cancer Center.
  • Stringer-Reasor EM; 28O'Neal Comprehensive Cancer Center at UAB.
  • Telli ML; 6Stanford Cancer Institute.
  • Ward JH; 29Huntsman Cancer Institute at the University of Utah.
  • Wisinski KB; 22University of Wisconsin Carbone Cancer Center.
  • Young JS; 30Roswell Park Comprehensive Cancer Center; and.
  • Burns JL; 31National Comprehensive Cancer Network.
  • Kumar R; 31National Comprehensive Cancer Network.
J Natl Compr Canc Netw ; 19(5): 484-493, 2021 05 01.
Article en En | MEDLINE | ID: mdl-34794122
ABSTRACT
The NCCN Guidelines for Breast Cancer include up-to-date guidelines for clinical management of patients with carcinoma in situ, invasive breast cancer, Paget disease, phyllodes tumor, inflammatory breast cancer, male breast cancer, and breast cancer during pregnancy. These guidelines are developed by a multidisciplinary panel of representatives from NCCN Member Institutions with breast cancer-focused expertise in the fields of medical oncology, surgical oncology, radiation oncology, pathology, reconstructive surgery, and patient advocacy. These NCCN Guidelines Insights focus on the most recent updates to recommendations for adjuvant systemic therapy in patients with nonmetastatic, early-stage, hormone receptor-positive, HER2-negative breast cancer.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Guideline Límite: Humans / Male Idioma: En Revista: J Natl Compr Canc Netw Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Guideline Límite: Humans / Male Idioma: En Revista: J Natl Compr Canc Netw Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article